Anandasabapathy Sharmila, Jhamb Jagriti, Davila Marta, Wei Caimiao, Morris Jeffrey, Bresalier Robert
Department of Gastroenterology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer. 2007 Feb 15;109(4):668-74. doi: 10.1002/cncr.22451.
Barrett esophagus is highly prevalent in the Western world; however, only a minority of affected individuals progress to esophageal adenocarcinoma. Whereas many studies have examined risk factors for development of Barrett metaplasia, few data are available on risk factors for progression to neoplasia. Identifying simple, reliable, clinical, and endoscopic predictors of high-grade dysplasia and adenocarcinoma would be helpful for risk stratification in screening and surveillance programs.
Clinical, endoscopic, and histologic data were reviewed for patients with a new Barrett diagnosis between 2002 and 2005. Patients were classified, by an expert gastrointestinal pathologist, as having intestinal metaplasia, indefinite-for-dysplasia, low-grade dysplasia, high-grade dysplasia, and esophageal adenocarcinoma. Gender, age, race, ethnicity, hiatal hernia presence and size, Barrett segment length, H. pylori status, alcohol, smoking, proton pump inhibitor (PPI) use and duration, and reflux symptom duration were evaluated by logistic regression analysis for their association with dysplasia severity.
In all, 109 patients (26 women, 83 men, mean age: 58.8) were newly diagnosed with Barrett metaplasia (n = 39), indefinite/low-grade dysplasia (n = 35), and high-grade dysplasia/esophageal adenocarcinoma (n = 35) over a 3-year period. On logistic regression analysis, duration of reflux symptoms for >or=20 years (odds ratio [OR]: 5.66, P = .012), longer Barrett segment length (OR for 3-6 cm vs. <3 cm: 9.05, P < .0001; OR for >or=6 cm: 8.374, P < .0001), hernia size >or=4 cm (OR: 10.63, P = .014), and male gender (OR: 4.03, P = .0019) were associated with higher pathologic grade. Duration of reflux symptoms and Barrett length were significant as both discrete and continuous variables. Absence of H. pylori (OR: 2.731, P = .060) approached significance in predicting dysplasia severity. In bivariate models, gender and Barrett length (continuous form) were significantly associated with grade when considered together (OR: 2.52, P = .0490 and OR: 1.30, P < .0001), as were gender and hernia size >4 cm (OR: 4.64, P = .0049 and OR: 12.18, P = .0197).
Male gender, longstanding gastroesophageal reflux disease, hiatal hernia size, and segment length are strongly associated with higher grades of dysplasia at index diagnosis. These factors along with H. pylori status warrant further prospective evaluation as predictors of risk for development of high-grade dysplasia and esophageal adenocarcinoma.
巴雷特食管在西方世界极为常见;然而,只有少数患者会进展为食管腺癌。尽管许多研究已探讨了巴雷特化生的危险因素,但关于进展为肿瘤形成的危险因素的数据却很少。识别出简单、可靠的临床和内镜下高级别异型增生及腺癌的预测指标,将有助于筛查和监测项目中的风险分层。
回顾了2002年至2005年间初诊为巴雷特食管的患者的临床、内镜及组织学数据。由一位胃肠道病理专家将患者分为肠化生、异型增生不明确、低级别异型增生、高级别异型增生和食管腺癌。通过逻辑回归分析评估性别、年龄、种族、民族、食管裂孔疝的存在及大小、巴雷特段长度、幽门螺杆菌感染状况、饮酒、吸烟、质子泵抑制剂(PPI)的使用及持续时间,以及反流症状持续时间与异型增生严重程度的相关性。
在3年期间,共有109例患者(26例女性,83例男性,平均年龄:58.8岁)初诊为巴雷特化生(n = 39)、异型增生不明确/低级别异型增生(n = 35)和高级别异型增生/食管腺癌(n = 35)。逻辑回归分析显示,反流症状持续时间≥20年(比值比[OR]:5.66,P = 0.012)、巴雷特段长度较长(3 - 6 cm 对比<3 cm的OR:9.05,P < 0.0001;≥6 cm的OR:8.374,P < .0001)、疝大小≥4 cm(OR:10.63,P = 0.014)以及男性(OR:4.03,P = 0.0019)与更高病理级别相关。反流症状持续时间和巴雷特段长度作为离散变量和连续变量均具有显著性。幽门螺杆菌阴性(OR:2.731,P = 0.060)在预测异型增生严重程度方面接近显著性。在二元模型中,性别和巴雷特段长度(连续形式)一起考虑时与级别显著相关(OR:2.52,P = 0.0490和OR:1.30,P < 0.0001),性别和疝大小>4 cm也是如此(OR:4.64,P = 0.0049和OR:12.18,P = 0.0197)。
男性、长期胃食管反流病、食管裂孔疝大小和段长度与初诊时更高等级的异型增生密切相关。这些因素以及幽门螺杆菌感染状况作为高级别异型增生和食管腺癌发生风险的预测指标值得进一步前瞻性评估。